Canadian Medication Appropriateness and Deprescribing Network

What Canadian Medication Appropriateness and Deprescribing Network does

The Canadian Medication Appropriateness and Deprescribing Network (CADeN) is a Montréal-based non-profit founded in 2015 that produces, disseminates, and curates evidence-based educational resources and clinical tools to reduce medication overload and promote safe, appropriate prescribing in Canada. Its core product is a publicly accessible website (deprescribingnetwork.ca) hosting deprescribing algorithms, patient handouts covering medication classes (sleeping pills, opioids, NSAIDs, antihistamines, antipsychotics, gabapentinoids, PPIs, diabetes medications), clinician education resources including whiteboard videos and curriculum materials, a medication review service finder covering provinces/territories, and a patient testimonial library. All materials are provided free of charge.

The organization operates a community-led go-to-market model, distributing content via direct website download, email newsletter, multilingual brochures, and public presentations that have reached hundreds of community groups across Canada. It serves five customer segments — healthcare providers, patients and the public, students, policymakers, and researchers — without any commercial transactional layer.

CADeN is funded entirely through financial contributions from public-sector grant providers: Canada's Drug Agency (formerly CADTH), Canadian Institutes of Health Research, and Accelerating Clinical Trials Canada. It is also a member of the Appropriate Use Coalition, a 10-organization grassroots alliance advancing appropriate prescribing. The network employs approximately 10 staff, including Assistant Director Camille Gagnon and Patient Awareness Committee Chair Janet Currie, and operates with data protection oversight from the Research Institute of the McGill University Health Centre. No revenue is disclosed, and the organization has no parent company, subsidiaries, M&A activity, or external equity investors.

Name

Canadian Medication Appropriateness and Deprescribing Network

Legal name

Canadian Medication Appropriateness and Deprescribing Network

Website

https://deprescribingnetwork.ca

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Non-profit network that produces and disseminates free evidence-based educational resources, deprescribing algorithms, and clinical tools to Canadian healthcare providers, patients, researchers, and policymakers to promote safe and appropriate medication use.

Ownership category

akta.pro rank

Product category

Healthcare Education and Advocacy

NAICS

Professional Organizations (81392)

SIC

Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Pharmacovigilance, Medication Safety & Controlled Substance Diversion Monitoring (HLAFALAN)

Keywords

• Medication deprescribing
• Medication safety education
• Clinical deprescribing algorithms
• Polypharmacy management
• Medication appropriateness resources

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Government Grants and Contributions: The organization is funded through financial contributions from government health agencies including Canada's Drug Agency, Canadian Institutes of Health Research, and Accelerating Clinical Trials Canada. These grants support the network's mission to promote safe medication use.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

The Canadian Medication Appropriateness and Deprescribing Network (CADeN) is a non-profit collaborative network that produces and disseminates free evidence-based educational resources, clinical deprescribing algorithms, patient handouts, brochures, clinician whiteboard videos, a medication review service finder, and policy resources to promote safe and appropriate medication use in Canada. All resources are freely available for download, print, and distribution, with multilingual translations for diverse communities.

Product overview

The Canadian Medication Appropriateness and Deprescribing Network (CADeN) is a clinician and researcher network that produces and disseminates educational resources, clinical tools, and informational materials to promote safe and appropriate medication use. The portfolio consists of a central website platform hosting deprescribing algorithms and organizational information, patient-facing handout brochures covering medication risks by class (sleeping pills, opioids, NSAIDs, antihistamines, antipsychotics, gabapentinoids, PPIs, diabetes medications), clinician education materials including whiteboard videos and curriculum resources, a medication review service finder tool, and a patient testimonial library. Additional resources include educational articles on medication and heat safety and antimicrobial resistance, sleep hygiene guidance, and shared decision-making tools.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Patient reduced medications from 30 to 18 daily with healthcare provider guidance

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Appropriate Use CoalitioncoreStrategic or Co-development PartnerA grassroots coalition of 10 organizations including the Canadian Medication Appropriateness and Deprescribing Network, committed to improving patient outcomes and reducing risks through appropriate prescribing.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• US Deprescribing Research Network: A US-based research and education network advancing deprescribing of inappropriate medications. Directly comparable to CADeN in mission (safer prescribing, reducing polypharmacy), stakeholder model (clinicians, researchers, patients), and resource categories (algorithms, education, policy).
• Choosing Wisely Canada: Canadian campaign helping clinicians and patients engage in conversations about unnecessary tests, treatments and medications. Overlaps with CADeN on the medication-appropriate-prescribing pillar and shares target audiences (clinicians, patients, policymakers).
• Institute for Safe Medication Practices Canada (ISMP Canada): A national non-profit dedicated to medication safety, error prevention and adverse event analysis. Highly comparable to CADeN's medication-safety mandate and Canadian non-profit, government-engaged operating model.
• Australian Deprescribing Network: An Australian national network producing evidence-based deprescribing resources, clinician education, and policy advocacy. Closely analogous to CADeN's structure as a country-level non-profit network with multi-stakeholder membership and government-aligned funding.

Others

• Canadian Pharmacists Association (CPhA): National professional association for pharmacists in Canada, providing medication-management resources, policy advocacy, and education. Adjacent to CADeN as a downstream professional channel that delivers deprescribing-aligned practice guidance to its pharmacist members.
• American Geriatrics Society (Beers Criteria): Publisher of the Beers Criteria for potentially inappropriate medication use in older adults. Conceptually analogous evidence-based tool to CADeN's deprescribing algorithms, addressing the same polypharmacy-in-older-adults problem with formal clinical authority.

Regional players

• Health Quality Ontario (Health Quality Ontario / Ontario Health): Provincial quality and safety body producing medication-safety guidance and quality standards in Ontario. Comparable as a jurisdictionally scoped (Canadian) authority overlapping CADeN's medication appropriateness, prescribing quality, and clinician-education remit.

Broad incumbents

• Choosing Wisely (ABIM Foundation): The US parent initiative behind Choosing Wisely Canada, advancing conversations on overuse in healthcare including inappropriate prescribing. Comparable as the originator of the model CADeN-aligned Canadian campaign builds on, with broader scope and resources.
• National Institute for Health and Care Excellence (NICE): UK body producing evidence-based clinical guidelines including medication management and deprescribing-related recommendations. Comparable as a broader, well-resourced authority whose guideline work intersects with CADeN's evidence-based algorithm and resource mission.

Emerging players

• Lown Institute: A US non-profit tackling overuse and underuse in healthcare, including medication appropriateness. Comparable as a like-minded advocacy organization with research, policy, and public-engagement programming similar to CADeN's community-led model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/canadian-deprescribing-network

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Medication Appropriateness and Deprescribing Network